Tenvie Therapeutics
Tenvie Therapeutics is a biotechnology company developing small molecule therapies for neurological and peripheral diseases, with two Phase 1 clinical programs underway. The company raised $200M in its Series A round in January 2025 and employs 53 people.
The growth story
Tenvie Therapeutics grew from 1 to 53 employees between 2023 and 2026, raising $200M along the way, most recently a Series A in January 2025.
About
Tenvie Therapeutics develops precision-engineered small molecule therapies targeting neuroinflammation and cellular dysfunction, which are core drivers of neurological and peripheral diseases. Its most advanced programs, TNV262 and TNV108, are in Phase 1 clinical trials, focusing on cardiometabolic, neuroinflammatory, and peripheral indications.
The company has raised $200M in a Series A round led by ARCH Venture Partners, F-Prime, and Mubadala Capital. With 53 employees, Tenvie is building its team to advance its clinical pipeline and proprietary product engine.
Founders and leadership
Tenvie Therapeutics is led by a team with expertise in biotechnology and drug development. The largest function within the company is Research, with 13 employees, reflecting its focus on advancing its clinical programs.
The Tenvie Therapeutics org chart
Tony Estrada (Co-Founder, President & CEO) leads 25 mapped leaders with 2 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 28 (+17% YoY), Operations 4 (+100% YoY), Business Development 4 (+33% YoY), Information Technology 3 (+200% YoY).
Talent flow
Tenvie’s team draws heavily from Denali Therapeutics (17 employees) and Genentech (8 employees), with additional talent from academic institutions like the University of California, San Francisco and Yale School of Medicine. Alumni have moved to companies such as Hale CMC Solutions, Septerna, and GondolaBio.
Most common previous employers of Tenvie Therapeutics staff: Denali Therapeutics (17), Genentech (8), University of California, San Francisco (3), Gilead Sciences (3), Sanofi (2), Yale School of Medicine (2). Former Tenvie Therapeutics employees most often moved to Hale CMC Solutions (1), Septerna (1), GondolaBio (1), IDEAYA Biosciences (1), Arc Institute (1), Calico Life Sciences (1).
Web traffic
Traffic mix: 49% direct, 28% search, 14% social, 2% paid.
What this company is made of
Most common skills at Tenvie Therapeutics: Research Skills (17), Biotechnology (16), Microsoft Office (15), Data Analysis (13), Drug Discovery (12), Drug Development (11), Polymerase Chain Reaction (PCR) (11), Histochemistry (10).
Where the team actually sits
Tenvie Therapeutics people are concentrated in California, United States (21), San Francisco Bay Area (11), United States (3), Greater Boston (2).
Search footprint
Tenvie Therapeutics attracts about 52 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 13 ranking keywords and lost 11 in the last period.
Frequently asked
Tenvie Therapeutics has 53 employees as of September 2026.
Tenvie Therapeutics has raised $200M in total, most recently a Series A round in January 2025.
Tenvie Therapeutics was founded in 2025 by Tony Estrada.
Tony Estrada (Co-Founder, President & CEO) sits at the top of Tenvie Therapeutics's reporting structure, with 2 direct reports.
The most common previous employers of current Tenvie Therapeutics staff are Denali Therapeutics (17 people), Genentech (8 people), University of California, San Francisco (3 people).
Former Tenvie Therapeutics employees most often move to Hale CMC Solutions (1), Septerna (1), GondolaBio (1).
Tenvie Therapeutics attracts about 52 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Tenvie Therapeutics staff are Research Skills, Biotechnology, Microsoft Office, Data Analysis, Drug Discovery.
Tenvie Therapeutics staff are concentrated in California, United States (21), San Francisco Bay Area (11), United States (3).
Tenvie Therapeutics has about 28 people in Research, up 17% over the past year, as of September 2026.
Tenvie Therapeutics has about 4 people in Operations, up 100% over the past year, as of September 2026.
Computed from 41 current and 12 former Tenvie Therapeutics profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.